Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion

Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Myakova, Natalia, Smirnova, Nadezhda, Evstratov, Dmitry, Abugova, Yulia, Balashov, Dmitry, Diakonova, Yulia, Konovalov, Dmitry, Skvortsova, Yulia, Maschan, Alexey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527816/
https://www.ncbi.nlm.nih.gov/pubmed/26273462
http://dx.doi.org/10.1002/ccr3.297
_version_ 1782384624272408576
author Myakova, Natalia
Smirnova, Nadezhda
Evstratov, Dmitry
Abugova, Yulia
Balashov, Dmitry
Diakonova, Yulia
Konovalov, Dmitry
Skvortsova, Yulia
Maschan, Alexey
author_facet Myakova, Natalia
Smirnova, Nadezhda
Evstratov, Dmitry
Abugova, Yulia
Balashov, Dmitry
Diakonova, Yulia
Konovalov, Dmitry
Skvortsova, Yulia
Maschan, Alexey
author_sort Myakova, Natalia
collection PubMed
description Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible relationship between both disorders was discussed.
format Online
Article
Text
id pubmed-4527816
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45278162015-08-13 Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion Myakova, Natalia Smirnova, Nadezhda Evstratov, Dmitry Abugova, Yulia Balashov, Dmitry Diakonova, Yulia Konovalov, Dmitry Skvortsova, Yulia Maschan, Alexey Clin Case Rep Case Reports Treatment of patients with refractory Hodgkin lymphoma is a significant issue. We report a patient with Proteus syndrome and relapsed Hodgkin lymphoma, whose remission was finally achieved after brentuximab vedotin therapy, allowing her to receive a haploidentical stem cell transplant. The possible relationship between both disorders was discussed. John Wiley & Sons, Ltd 2015-07 2015-06-11 /pmc/articles/PMC4527816/ /pubmed/26273462 http://dx.doi.org/10.1002/ccr3.297 Text en © 2015 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Myakova, Natalia
Smirnova, Nadezhda
Evstratov, Dmitry
Abugova, Yulia
Balashov, Dmitry
Diakonova, Yulia
Konovalov, Dmitry
Skvortsova, Yulia
Maschan, Alexey
Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title_full Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title_fullStr Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title_full_unstemmed Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title_short Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion
title_sort brentuximab vedotin in the treatment of a patient with refractory hodgkin disease and proteus syndrome – a case report and discussion
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527816/
https://www.ncbi.nlm.nih.gov/pubmed/26273462
http://dx.doi.org/10.1002/ccr3.297
work_keys_str_mv AT myakovanatalia brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT smirnovanadezhda brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT evstratovdmitry brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT abugovayulia brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT balashovdmitry brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT diakonovayulia brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT konovalovdmitry brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT skvortsovayulia brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion
AT maschanalexey brentuximabvedotininthetreatmentofapatientwithrefractoryhodgkindiseaseandproteussyndromeacasereportanddiscussion

Ejemplares similares